Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 881

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 881
---
SET BOULEVARD, SUITE A250 Before The Meeting - Go to www.proxyvote.com or scan the QR Barcode above PACIFIC PALISADES, CA 90272 Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time on [___], 2025. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. During The Meeting - Go to www.virtualshareholdermeeting.com/AADI2025SM You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions. VOTE BY PHONE - 1-800-690-6903 Use any touch-tone telephone to transmit your voting instructions up until 11:59 p.m. Eastern Time on [___], 2025. Have your proxy card in hand when you call and then follow the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: V61172-TBD KEEP THIS PORTION FOR YOUR RECORDS THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY AADI BIOSCIENCE, INC. The Board of Directors recommends you vote FOR the following proposals: For Against Abstain 1. Divestiture Proposal. To approve the sale by Aadi to KAKEN INVESTMENTS INC. of 100% of the outstanding shares of capital stock of Aadi Subsidiary, Inc. and thereby all or substantially all of Aadi’s assets related to its FYARRO® (sirolimus protein-bound particles for injectable suspension) (albumin-bound) program, pursuant to the terms of a stock purchase agreement, dated December 19, 2024, as it may be amended from time to time, which may be deemed to be a sale of substantially all of Aadi’s assets under Section 271 of the Delaware General Corporation Law, as amended. 2. The PIPE Financing Proposal. To approve, for purposes of complying with the applicable provisions of Nasdaq Listing Rule 5635, the issuance of an ! ! !